These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6330541)

  • 21. Effect of suloctidil on platelet function in patients with shortened platelet survival time.
    Turpie AG; Gent M; deBoer AC; Giroux M; Kinch D; Butt R; Gunstensen J; Saerens E; Genton E
    Thromb Res; 1984 Aug; 35(4):397-406. PubMed ID: 6091290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
    Baro F; Malfroid M; Waegemans T; Cox JP
    Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind trial of suloctidil v. placebo in intermittent claudication.
    Jones NA; De Haas H; Zahavi J; Kakkar VV
    Br J Surg; 1982 Jan; 69(1):38-40. PubMed ID: 6274471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of the blood platelets in the atherosclerotic process and clinical use of a new drug, Suloctidil, with anti-aggregating activity].
    Armani U; Piana A
    Arch Maragliano Patol Clin; 1979; 35(2):57-62. PubMed ID: 233645
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
    Spinella G; Majorana M
    Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency].
    Beĭn BN; Dravert NE
    Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
    Petronio G; Scali G; Casa B; Nonis E
    Clin Ter; 1980 Aug; 94(4):427-44. PubMed ID: 6257445
    [No Abstract]   [Full Text] [Related]  

  • 28. Controlled trial of suloctidil in intermittent claudication.
    Verhaeghe R; Van Hoof A; Beyens G
    J Cardiovasc Pharmacol; 1981; 3(2):279-86. PubMed ID: 6166799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nootropics: status and prospects.
    Itil TM
    Biol Psychiatry; 1983 May; 18(5):521-3. PubMed ID: 6305429
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of suloctidil on cerebral circulation patterns of conscious rabbits.
    Rozza Dionigi A; Lanza E; Favalli L; Carminati GM; Piccinini F
    Arzneimittelforschung; 1986 Feb; 36(2):194-6. PubMed ID: 3008769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of suloctidil in the prevention of deep vein thrombosis in neurosurgical patients.
    Turpie AG; Gent M; Doyle DJ; Saerens E; de Boer AC; Talbot C; McNamee J; Hirsh J
    Thromb Res; 1985 Jul; 39(2):173-81. PubMed ID: 2992116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of suloctidil in the protection of the cerebral function].
    Nishi H; Kadowaki S; Endo N
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):37-46. PubMed ID: 6311699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A new preparation for peripheral arterial occlusive diseases].
    Knüchel F
    Med Welt; 1982 Jan; 33(1):90. PubMed ID: 6276645
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypocholesterolaemic activity of suloctidil: double-blind, crossover short-term and long-term treatment trial.
    Chieffo C; Postiglione A; Tritto C; Mancini M
    Curr Med Res Opin; 1984; 9(3):147-52. PubMed ID: 6094103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double blind trial with suloctidil, a new vasoactive agent, in elderly patients with psycho-organic brain syndrome.
    Jacquy J; Noel G
    Acta Clin Belg; 1977; 32(1):22-6. PubMed ID: 331821
    [No Abstract]   [Full Text] [Related]  

  • 36. A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke.
    Gent M; Blakely JA; Hachinski V; Roberts RS; Barnett HJ; Bayer NH; Carruthers SG; Collins SM; Gawel MG; Giroux-Klimek M
    Stroke; 1985; 16(3):416-24. PubMed ID: 2988158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CAROTID-VERTEBRAL ARTERY STENOSIS AND OCCLUSION.
    ROBERTS B
    Practitioner; 1965 Feb; 194():214-9. PubMed ID: 14259704
    [No Abstract]   [Full Text] [Related]  

  • 38. [Protective effect of suloctidil against cerebral hypoxia (author's transl)].
    Hori N; Nishi H; Katsuda N
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):655-65. PubMed ID: 6260603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of suloctidil on tomographically quantitated platelet accumulation in Dacron aortic grafts.
    Stratton JR; Ritchie JL
    Am J Cardiol; 1986 Jul; 58(1):152-6. PubMed ID: 3014851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of suloctidil on the reduced evoked potentials in brain slices in low glucose perfusate].
    Nishi H; Hori N; Katsuda N
    Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):321-33. PubMed ID: 6323287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.